Dimerix Bioscience Pty Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 7, 2027The maintenance fee for Combination therapy (US 10,525,038) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Combination therapy (US 9,314,450) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,058,555 | Combination therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 10,525,038 | Combination therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 12,083,102 | Method for treating inflammatory disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 11,382,896 | Method for treating inflammatory disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 9,314,450 | Combination therapy In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 5: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 4 no status recorded
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/774,024 | Jul 16, 2024 | No status recorded | |
| 18/282,105 | Treatment of Inflammatory Diseases | Mar 18, 2022 | Pending |
| 18/718,617 | Compositions Comprising a Chemokine Receptor Pathway Inhibitor | Jan 14, 2022 | Pending |
| 17/675,320 | Sep 18, 2020 | No status recorded | |
| 13/260,530 | Mar 26, 2010 | No status recorded | |
| 12/514,034 | Nov 9, 2007 | No status recorded |